CooperVision, Inc.
coopervision.comTotal trials
154
Active
2
Phase 3
0
Total enrollment
11,198
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Myopia98
- Astigmatism33
- Presbyopia16
- Ametropia11
- Hyperopia10
- Astigmatism Bilateral2
- Refractive Error1
- Contact Lens Solutions1
Frequently asked questions about CooperVision, Inc.
- How many clinical trials does CooperVision, Inc. have on ClinicalTrials.gov?
- CooperVision, Inc. is listed as the lead sponsor on 154 clinical trials in ClinicalTrials.gov, 2 of which are currently active (recruiting, enrolling, or ongoing).
- How many of CooperVision, Inc.'s trials are in Phase 3?
- 0 of CooperVision, Inc.'s trials are in Phase 3.
- What therapeutic areas does CooperVision, Inc. focus on?
- CooperVision, Inc.'s most-studied conditions on ClinicalTrials.gov are Myopia, Astigmatism, Presbyopia, Ametropia, Hyperopia.